Guidelines and definitions for research on epithelial–mesenchymal transition

Jing Yang(University of California San Diego), Parker B. Antin(University of Arizona), Geert Berx(Ghent University), Cédric Blanpain(Université Libre de Bruxelles), Thomas Brabletz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Marianne Bronner‐Fraser(California Institute of Technology), Kyra Campbell(University of Sheffield), Amparo Cano(Instituto de Investigaciones Biomédicas Sols-Morreale), Jordi Casanova(Institute for Research in Biomedicine), Gerhard Christofori(University of Basel), Shoukat Dedhar(University of British Columbia), Rik Derynck(University of California, San Francisco), Heide L. Ford(University of Colorado Anschutz Medical Campus), Jonas Fuxe(Karolinska University Hospital), Antonio García de Herreros(Universitat Pompeu Fabra), Gregory J. Goodall(South Australia Pathology), Anna‐Katerina Hadjantonakis(Memorial Sloan Kettering Cancer Center), Ruby Yun‐Ju Huang(National Taiwan University), Chaya Kalcheim(Hebrew University of Jerusalem), Raghu Kalluri(The University of Texas MD Anderson Cancer Center), Yibin Kang(Princeton University), Yeesim Khew‐Goodall(South Australia Pathology), Herbert Levine(Northeastern University), Jinsong Liu(The University of Texas MD Anderson Cancer Center), Gregory D. Longmore(Washington University in St. Louis), Sendurai A. Mani(The University of Texas MD Anderson Cancer Center), Joan Massagué(Memorial Sloan Kettering Cancer Center), Roberto Mayor(University College London), David R. McClay(Duke University), Keith E. Mostov(University of California, San Francisco), Donald F. Newgreen(Royal Children's Hospital), M. Ángela Nieto(Instituto de Neurociencias), Alain Puisieux(Université Claude Bernard Lyon 1), Raymond B. Runyan(University of Arizona), Pierre Savagner(Inserm), Ben Z. Stanger(University of Pennsylvania), Marc P. Stemmler(Friedrich-Alexander-Universität Erlangen-Nürnberg), Yoshiko Takahashi(Kyoto University), Masatoshi Takeichi(RIKEN Center for Biosystems Dynamics Research), Eric Théveneau(Centre National de la Recherche Scientifique), Jean Paul Thiery(Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Erik W. Thompson(Translational Research Institute), Robert A. Weinberg(Molecular Oncology (United States)), Elizabeth D. Williams(Queensland University of Technology), Jianhua Xing(UPMC Hillman Cancer Center), Binhua P. Zhou(University of Kentucky), Guojun Sheng(Kumamoto University)
Nature Reviews Molecular Cell Biology
April 16, 2020
Cited by 2,282Open Access
Full Text

Abstract

Epithelial-mesenchymal transition (EMT) encompasses dynamic changes in cellular organization from epithelial to mesenchymal phenotypes, which leads to functional changes in cell migration and invasion. EMT occurs in a diverse range of physiological and pathological conditions and is driven by a conserved set of inducing signals, transcriptional regulators and downstream effectors. With over 5,700 publications indexed by Web of Science in 2019 alone, research on EMT is expanding rapidly. This growing interest warrants the need for a consensus among researchers when referring to and undertaking research on EMT. This Consensus Statement, mediated by 'the EMT International Association' (TEMTIA), is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications. We trust that these guidelines will help to reduce misunderstanding and misinterpretation of research data generated in various experimental models and to promote cross-disciplinary collaboration to identify and address key open questions in this research field. While recognizing the importance of maintaining diversity in experimental approaches and conceptual frameworks, we emphasize that lasting contributions of EMT research to increasing our understanding of developmental processes and combatting cancer and other diseases depend on the adoption of a unified terminology to describe EMT.


Related Papers